Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day
admin First the good news: Pfizer Inc. and Germany-based partner BioNTech SE said updated trial data…
Read Moregovernment policy
Rohit Chopra is cracking down on big banks and Big Tech. Is he out of control?
In March, Rohit Chopra was invited to give a virtual speech at the University of…
Read MoreLatinos are crucial to the economy — but banks don’t always meet their needs
When it comes to banking, Mireya Olvera knows that Latino consumers want to feel understood…
Read MoreWhy U.S. midterm election matters to crypto, and how
Hello, welcome back to Distributed Ledger, our weekly crypto newsletter that reaches your inbox every…
Read MoreVonage to pay $100 million to settle FTC allegations of thwarting cancellations, ‘junk fees’
Internet-based telecom provider Vonage agreed to pay $100 to the Federal Trade Commission to settle…
Read MoreOpinion: Investors in drug stocks should ignore dubious valuations based on rigged methodologies
The investment firm Morningstar has announced that it will now pick drug stocks based upon…
Read MoreFeds break up multimillion-dollar, multistate catalytic-converter theft ring
Federal authorities took a big crack at catalytic converter thefts, announcing raids and arrests from…
Read MoreWeekly tally of COVID cases and deaths continues to fall; Moderna lowers vaccine-sales outlook by as much as $3 billion
The global tally of COVID-19 cases fell 17% in the week through Oct. 30 from…
Read MoreWeekly tally of COVID cases and deaths continues to fall; Moderna lowers vaccine-sales outlook by as much as $3 billion
The global tally of COVID-19 cases fell 17% in the week through Oct. 30 from…
Read More
These money and investing tips can set you straight in this roller-coaster market
Don’t miss these top money and investing features: Sign up here to get MarketWatch’s best…
Read More